• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲环素A的基因缺陷和多态性揭示了其对人冠状病毒229E复制的重要作用。

Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication.

作者信息

von Brunn Albrecht, Ciesek Sandra, von Brunn Brigitte, Carbajo-Lozoya Javier

机构信息

Max-von-Pettenkofer Institute, Ludwig-Maximilians-Universität, München, Germany; German Center for Infection Research (DZIF), Germany.

German Center for Infection Research (DZIF), Germany; Department of Gastroenterology, Hepatology und Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany.

出版信息

Curr Opin Virol. 2015 Oct;14:56-61. doi: 10.1016/j.coviro.2015.08.004. Epub 2015 Aug 27.

DOI:10.1016/j.coviro.2015.08.004
PMID:26318518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7102849/
Abstract

Replication of coronaviruses is inhibited in vitro by cyclosporin A, a well-known immunosuppressive drug which binds to cellular cyclophilins thus inactivating their enzymatic cis-trans peptidyl-prolyl isomerase function. Latter is required for proper folding of cellular proteins and of proteins of several viruses. Here, we summarize present knowledge on the role of cyclophilin A during coronavirus replication. We present data on the effect of cyclophilin A single nucleotide polymorphism mutants on the replication of human CoV-229E demonstrating the requirement of proper cyclophilin A function for virus propagation. Results define cellular cyclophilin A as a host target for inhibition of coronaviruses ranging from relatively mild common cold to highly pathogenic SARS-CoV and MERS-CoV viruses with the perspective of disclosing non-immunosuppressive cyclosporin A analogs to broadly inactivate the coronavirus family.

摘要

环孢素A可在体外抑制冠状病毒的复制,环孢素A是一种著名的免疫抑制药物,它与细胞亲环蛋白结合,从而使其酶促顺反肽基-脯氨酰异构酶功能失活。后者是细胞蛋白和几种病毒蛋白正确折叠所必需的。在此,我们总结了目前关于亲环蛋白A在冠状病毒复制过程中作用的知识。我们展示了亲环蛋白A单核苷酸多态性突变体对人冠状病毒229E复制影响的数据,证明了亲环蛋白A的正常功能对病毒传播的必要性。研究结果将细胞亲环蛋白A定义为抑制冠状病毒的宿主靶点,这些冠状病毒包括相对温和的普通感冒病毒以及高致病性的严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒,有望揭示非免疫抑制性环孢素A类似物以广泛灭活冠状病毒家族。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90d0/7102849/b6dc169e7a73/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90d0/7102849/611a423cc997/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90d0/7102849/b6dc169e7a73/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90d0/7102849/611a423cc997/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90d0/7102849/b6dc169e7a73/gr2_lrg.jpg

相似文献

1
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication.亲环素A的基因缺陷和多态性揭示了其对人冠状病毒229E复制的重要作用。
Curr Opin Virol. 2015 Oct;14:56-61. doi: 10.1016/j.coviro.2015.08.004. Epub 2015 Aug 27.
2
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.环孢素 A 和非免疫抑制剂衍生物在人冠状病毒 229E 复制过程中对细胞亲环素和病毒核衣壳蛋白的影响。
Antiviral Res. 2020 Jan;173:104620. doi: 10.1016/j.antiviral.2019.104620. Epub 2019 Oct 18.
3
[Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].[亲环素A在冠状病毒复制过程中的作用及其抑制剂的抗病毒活性]
Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):605-611. doi: 10.13345/j.cjb.200049.
4
Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.免疫亲和素抑制剂和非免疫抑制剂类似物对人感染模型中冠状病毒复制的影响。
Front Cell Infect Microbiol. 2022 Sep 21;12:958634. doi: 10.3389/fcimb.2022.958634. eCollection 2022.
5
Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B.猫冠状病毒的复制受亲环蛋白A和亲环蛋白B两者的影响。
J Gen Virol. 2017 Feb;98(2):190-200. doi: 10.1099/jgv.0.000663. Epub 2017 Mar 13.
6
Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication.鉴定感染人类冠状病毒的细胞的脂质组特征:对冠状病毒复制时脂质代谢重编程的影响。
Viruses. 2019 Jan 16;11(1):73. doi: 10.3390/v11010073.
7
Cyclophilins and cyclophilin inhibitors in nidovirus replication.冠状病毒复制中的亲环素和亲环素抑制剂。
Virology. 2018 Sep;522:46-55. doi: 10.1016/j.virol.2018.06.011. Epub 2018 Jul 12.
8
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.人冠状病毒 NL63 的复制依赖于亲环素 A,并受非免疫抑制性环孢菌素 A 衍生物(包括阿利司匹韦)的抑制。
Virus Res. 2014 May 12;184:44-53. doi: 10.1016/j.virusres.2014.02.010. Epub 2014 Feb 22.
9
Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture.冠状病毒和动脉炎病毒在细胞培养复制过程中,对亲环素A的依赖性表现出显著差异。
Virology. 2018 Apr;517:148-156. doi: 10.1016/j.virol.2017.11.022. Epub 2017 Dec 15.
10
Suppression of coronavirus replication by cyclophilin inhibitors.环孢素抑制剂抑制冠状病毒复制。
Viruses. 2013 May 22;5(5):1250-60. doi: 10.3390/v5051250.

引用本文的文献

1
Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients.伏环孢素对免疫功能低下的肾脏患者抗SARS-CoV-2的抗病毒作用
Kidney Int Rep. 2023 Sep 7;8(12):2654-2664. doi: 10.1016/j.ekir.2023.09.003. eCollection 2023 Dec.
2
Cyclophilin A-mediated mitigation of coronavirus SARS-CoV-2.亲环素A介导的新型冠状病毒SARS-CoV-2缓解作用
Bioeng Transl Med. 2023 Mar;8(2):e10436. doi: 10.1002/btm2.10436. Epub 2022 Oct 27.
3
The Cyclophilin-Dependent Calcineurin Inhibitor Voclosporin Inhibits SARS-CoV-2 Replication in Cell Culture.

本文引用的文献

1
Cyclophilin polymorphism and virus infection.亲环蛋白多态性与病毒感染。
Curr Opin Virol. 2015 Oct;14:47-9. doi: 10.1016/j.coviro.2015.07.012. Epub 2015 Aug 13.
2
Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection.用于治疗慢性病毒感染的优化亲环素抑制剂的生物工程与半合成
Chem Biol. 2015 Feb 19;22(2):285-92. doi: 10.1016/j.chembiol.2014.10.023. Epub 2015 Jan 22.
3
The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
环孢素 D 依赖性钙调神经磷酸酶抑制剂伏环孢素抑制细胞培养中的 SARS-CoV-2 复制。
Transpl Int. 2022 Jun 24;35:10369. doi: 10.3389/ti.2022.10369. eCollection 2022.
4
Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.环孢素 A 抑制剂的再利用作为广谱抗病毒药物。
Drug Discov Today. 2022 Jul;27(7):1895-1912. doi: 10.1016/j.drudis.2022.05.016. Epub 2022 May 21.
5
Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.免疫检测分析法定量检测季节性普通感冒冠状病毒 OC43、NL63 或 229E 感染,证实奈玛特韦是一种广谱冠状病毒抑制剂。
Antiviral Res. 2022 Jul;203:105343. doi: 10.1016/j.antiviral.2022.105343. Epub 2022 May 19.
6
Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).蛋白质的分子机制——SARS-CoV-2 的靶点(综述)。
Sovrem Tekhnologii Med. 2021;12(6):98-108. doi: 10.17691/stm2020.12.6.11. Epub 2020 Dec 28.
7
A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease.新型冠状病毒肺炎综述:冠状病毒病的治疗策略及CRISPR/Cas9基因编辑技术方法
Saudi J Biol Sci. 2022 Feb;29(2):860-871. doi: 10.1016/j.sjbs.2021.10.020. Epub 2021 Oct 13.
8
The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.SARS-CoV-2 核衣壳 N 端结构域的固有动力学和相互作用位点。
J Mol Biol. 2021 Jul 23;433(15):167108. doi: 10.1016/j.jmb.2021.167108. Epub 2021 Jun 20.
9
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2.药物重定位筛选揭示了针对 SARS-CoV-2 的细胞类型特异性进入途径和已获 FDA 批准的药物。
Cell Rep. 2021 Apr 6;35(1):108959. doi: 10.1016/j.celrep.2021.108959. Epub 2021 Mar 23.
10
A CRISPR response to pandemics?: Exploring the ethics of genetically engineering the human immune system.CRISPR 应对大流行?:探索基因工程改造人类免疫系统的伦理问题。
EMBO Rep. 2021 Mar 3;22(3):e52319. doi: 10.15252/embr.202052319. Epub 2021 Feb 21.
严重急性呼吸综合征冠状病毒木瓜样蛋白酶:结构、功能及设计的抗病毒化合物对其的抑制作用
Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29.
4
Polymorphisms in the feline TNFA and CD209 genes are associated with the outcome of feline coronavirus infection.猫科动物肿瘤坏死因子α(TNFA)和CD209基因的多态性与猫冠状病毒感染的结果相关。
Vet Res. 2014 Dec 16;45(1):123. doi: 10.1186/s13567-014-0123-6.
5
Multidomain Peptidyl Prolyl cis/trans Isomerases.多结构域肽基脯氨酰顺/反异构酶
Biochim Biophys Acta. 2015 Oct;1850(10):2005-16. doi: 10.1016/j.bbagen.2014.11.012. Epub 2014 Nov 18.
6
The role of immunophilins in viral infection.亲免素在病毒感染中的作用。
Biochim Biophys Acta. 2015 Oct;1850(10):2103-10. doi: 10.1016/j.bbagen.2014.11.011. Epub 2014 Nov 18.
7
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment.丙型肝炎病毒和干扰素 III 型(干扰素-λ3/白细胞介素-28B 和干扰素-λ4):感染易感性和抗病毒治疗反应的遗传基础。
Clin Microbiol Infect. 2014 Dec;20(12):1237-45. doi: 10.1111/1469-0691.12797. Epub 2014 Dec 12.
8
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design.从非典到中东呼吸综合征:冠状病毒蛋白酶的晶体学研究助力抗病毒药物设计。
FEBS J. 2014 Sep;281(18):4085-96. doi: 10.1111/febs.12936. Epub 2014 Aug 11.
9
Antiviral drugs specific for coronaviruses in preclinical development.处于临床前开发阶段的针对冠状病毒的抗病毒药物。
Curr Opin Virol. 2014 Oct;8:45-53. doi: 10.1016/j.coviro.2014.06.002. Epub 2014 Jul 2.
10
Identification and genotyping of feline infectious peritonitis-associated single nucleotide polymorphisms in the feline interferon-γ gene.鉴定和基因分型猫传染性腹膜炎相关的猫干扰素-γ基因中的单核苷酸多态性。
Vet Res. 2014 May 21;45(1):57. doi: 10.1186/1297-9716-45-57.